CENTRAL RAILWAY has floated a tender for Inj Adalimumab 40 Mg 0.8 Ml Pfs - Exemptia 40 Mg. The project location is Mumbai, Maharashtra, India. The reference number is CRM181970005NGP and it is closing on 25 Jan 2018.
Suppliers can request Register free of cost to get the complete Tender details and download the document.